Article
Dilated cardiomyopathy in mucolipidosis type 2.
Journal of biological regulators and homeostatic agents - 1 Jan 2000
Carboni E, Sestito S, Lucente M, Morrone A, Zampini L, Chimenz R, Ceravolo M D, De Sarro R, Ceravolo G, Calabrò M P, Parisi F, Moricca M T, Pensabene L, Musolino D, Concolino D
Abstract excerpt
Mucolipidosis II and III are lysosomal storage diseases caused by pathogenetic mutations in GNPTAB and GNPTG genes which cause an impaired activity of the lysosomal hydrolase N-acetylglucosamine- 1-phosphotransferase, a key enzyme in the synthesis of the mannose-6-phosphate targeting signals on lysosomal enzymes. Patients with MLII alpha/beta present coarse facial features, cessation of statural growth, important...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
